ANR ASX · Health Care

Anatara Lifesciences Ltd

Announcements, last 12 months: 29
Price sensitive, last 12 months: 9
Followed on InvestorPA: Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
23 Oct 2026, 1:11 PM	Notice of Annual General Meeting/Proxy Form
23 Oct 2026, 1:07 PM	Appendix 4G & Corporate Governance Statement
23 Oct 2026, 1:05 PM	Annual Report to shareholders
13 Oct 2026, 10:58 AM	Quarterly Activities/Appendix 4C Cash Flow Report Price sensitive	AI summary
24 Sep 2026, 8:47 AM	Date of 2026 Annual General Meeting
15 Sep 2026, 9:40 AM	Anatara receives $318,402 in R&D Tax Incentive for FY26 Price sensitive	AI summary
24 Aug 2026, 5:15 PM	Change of Director's Interest Notice
24 Aug 2026, 5:13 PM	Application for quotation of securities - ANR
24 Aug 2026, 5:10 PM	Conversion of Performance Rights and Cleansing Notice
18 Aug 2026, 6:18 PM	Appendix 4E & Financial Report 30 June 2026 Price sensitive	AI summary

Sign in to see all ANR announcements.

Guidance history

13 Oct 2026	Anatara Lifesciences Ltd received a $318,402 R&D tax incentive rebate as anticipated.
31 Jul 2026	Anatara Lifesciences Ltd expects a rebate of over $300K from the R&D tax incentive claim.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow ANR to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.